HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $228,834 | -38.0% | 5,992 | -7.6% | 0.01% | -54.5% |
Q4 2022 | $368,826 | +44.1% | 6,482 | +0.2% | 0.01% | +22.2% |
Q3 2022 | $256,000 | +0.8% | 6,466 | +12.2% | 0.01% | -18.2% |
Q2 2022 | $254,000 | +10.9% | 5,765 | +0.3% | 0.01% | +22.2% |
Q1 2022 | $229,000 | -0.9% | 5,750 | 0.0% | 0.01% | +12.5% |
Q4 2021 | $231,000 | +13.8% | 5,750 | +15.0% | 0.01% | 0.0% |
Q3 2021 | $203,000 | -11.7% | 5,000 | -1.1% | 0.01% | -11.1% |
Q2 2021 | $230,000 | -12.9% | 5,055 | -20.0% | 0.01% | -25.0% |
Q1 2021 | $264,000 | +14.8% | 6,321 | +17.3% | 0.01% | 0.0% |
Q4 2020 | $230,000 | – | 5,387 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |